Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MetPath's biggest test

S D Solomon

    Fortune
    |March 9, 1978
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease. Circulation 116: 2687-2693, 2007.

    Clinical journal of the American Society of Nephrology : CJASN·2023
    Same author

    Recovering is about <i>living my life, as it evolves</i>: perspectives of stroke survivors in remote northwest Queensland.

    Disability and rehabilitation·2021
    Same author

    Filtration Markers, Cardiovascular Disease, Mortality, and Kidney Outcomes in Stable Kidney Transplant Recipients: The FAVORIT Trial.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
    Same author

    Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trial.

    Diabetes, obesity & metabolism·2015
    Same author

    Pulse pressure is not an independent predictor of outcome in type 2 diabetes patients with chronic kidney disease and anemia--the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT).

    Journal of human hypertension·2015
    Same author

    First-in-class angiotensin receptor neprilysin inhibitor in heart failure.

    Clinical pharmacology and therapeutics·2013
    Same journal

    THE RIDDLE OF THE WALL IN THE BRAIN.

    Fortune·2016
    Same journal

    BLOOD TESTING IS BOOMING.

    Fortune·2016
    Same journal

    INTO THE LIGHT.

    Fortune·2016
    Same journal

    BIG INNOVATION IN SMALL PLACES.

    Fortune·2016
    Same journal

    HACKER BAD BOY VENTURE CAPITALIST DISRUPTER HEALER.

    Fortune·2016
    Same journal

    THE FIGHT TO DOMINATE BIG PHARMA(CY).

    Fortune·2016
    See all related articles